While DOXO-induced oxidative stress and NF-κB activation are well documented, our findings are the first to demonstrate that selective AURKA inhibition can simultaneously downregulate the IL-17A-driven STAT3/HIF-1α/TGF-β1/VEGF-A axis in DOXO-induced liver injury. This evidence concerns the gene VEGFA and injury.